Journal of Alzheimers Disease

Article	Citations
Neurobiology of COVID-19	288
Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease	182
Heavy Metals Exposure and Alzheimer’s Disease and Related Dementias	136
The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer’s Disease During the COVID-19 Crisis	109
Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer’s Disease: A Systematic Review	94
Potential Novel Role of COVID-19 in Alzheimer’s Disease and Preventative Mitigation Strategies	92
Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial	89
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer’s Disease or Mild Cognitive Impairment	86
Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer’s Disease Dementia in a Large National Survey	83
Association of COVID-19 with New-Onset Alzheimer’s Disease	80
Alzheimer’s Disease: The Link Between Amyloid-β and Neurovascular Dysfunction	75
Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases	74
Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data	73
The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis	72
Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study	71
Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline	70
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer’s Disease	69
SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer’s Disease	68
Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment	67
The Trajectory of Caregiver Burden and Risk Factors in Dementia Progression: A Systematic Review	67
Therapeutic Potential of TNF-α Inhibition for Alzheimer’s Disease Prevention	67
Promoting Successful Cognitive Aging: A Ten-Year Update	65
Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer’s Disease: A Systematic Review	63
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications	61
Alzheimer’s Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains	59

Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer’s Disease	59
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures	58
Air Pollution and Alzheimer’s Disease: A Systematic Review and Meta-Analysis	58
Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial	57
Is Alzheimer’s Disease a Liver Disease of the Brain?	57
NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer’s Disease	56
Vitamin D Supplementation Improves Cognitive Function Through Reducing Oxidative Stress Regulated by Telomere Length in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized Controlled Tr	54
Brain Perfusion Change in Patients with Mild Cognitive Impairment After 12 Months of Aerobic Exercise Training	53
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration	53
Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management	52
The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review	52
Depression is Associated with Tau and Not Amyloid Positron Emission Tomography in Cognitively Normal Adults	51
The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer’s Disease	50
Benfotiamine and Cognitive Decline in Alzheimer’s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial	49
Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care	48
One-Year Aerobic Exercise Reduced Carotid Arterial Stiffness and Increased Cerebral Blood Flow in Amnestic Mild Cognitive Impairment	48
tRNA-Derived Fragments in Alzheimer’s Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms	48
Impact of Social Isolation on People with Dementia and Their Family Caregivers	48
Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study	44
The Potential Role of Ferroptosis in Alzheimer’s Disease	44
The Role of Microglia in Sporadic Alzheimer’s Disease	43
Alzheimer’s Disease Neuropathological Comorbidities are Common in the Younger-Old	42
Mesenchymal Stem Cell Therapy and Alzheimer’s Disease: Current Status and Future Perspectives	42
Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer’s Disease1	41
High Salt Elicits Brain Inflammation and Cognitive Dysfunction, Accompanied by Alternations in the Gut Microbiota and Decreased SCFA Production	41
Dementia in the COVID-19 Period	41
New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer’s Disease	41
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage1	40
Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic	40
A Randomized Clinical Trial of Greek High Phenolic Early Harvest Extra Virgin Olive Oil in Mild Cognitive Impairment: The MICOIL Pilot Study	39
Is the Frontal Lobe the Primary Target of SARS-CoV-2?	39
A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease	39
Cognitive Correlates of Digital Clock Drawing Metrics in Older Adults with and without Mild Cognitive Impairment	38
Astrocytic TSPO Upregulation Appears Before Microglial TSPO in Alzheimer’s Disease	38
A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer’s Disease Transgenic Mice	37
Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer’s Disease Cooperative Study-Sponsored DHA Clinical Trial	37
Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy	37
Dietary Pattern, Diet Quality, and Dementia: A Systematic Review and Meta-Analysis of Prospective Cohort Studies	37
Death Rate Due to COVID-19 in Alzheimer’s Disease and Frontotemporal Dementia	36
Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias	36
Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer’s Disease Treated with Escalating Doses for up to 133 Weeks	36
Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching	36
The Latin America and the Caribbean Consortium on Dementia (LAC-CD): From Networking to Research to Implementation Science	36
Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease	36
Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research	35
High Cholesterol Diet Exacerbates Blood-Brain Barrier Disruption in LDLr–/– Mice: Impact on Cognitive Function	35
GABAB Receptor-Mediated PI3K/Akt Signaling Pathway Alleviates Oxidative Stress and Neuronal Cell Injury in a Rat Model of Alzheimer’s Disease	35
Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain	35
Life Course Air Pollution Exposure and Cognitive Decline: Modelled Historical Air Pollution Data and the Lothian Birth Cohort 1936	35
Association of Stress with Risk of Dementia and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis	35

Cognitive Effects of Treating Obstructive Sleep Apnea: A Meta-Analysis of Randomized Controlled Trials	35
Brief Cognitive Tests Used in Primary Care Cannot Accurately Differentiate Mild Cognitive Impairment from Subjective Cognitive Decline	34
The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports	34
COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers’ Poor Mental Health	34
Costs of Early Stage Alzheimer’s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1	34
A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease	34
Photobiomodulation for Alzheimer’s Disease: Translating Basic Research to Clinical Application	33
Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy	33
Particulate Matter Exposure Exacerbates Amyloid-β Plaque Deposition and Gliosis in APP/PS1 Mice	33
IL-1β, IL-6, IL-10, and TNFα Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer’s Disease Pathology	33
High Dietary Advanced Glycation End Products Impair Mitochondrial and Cognitive Function	33
Structural Change of Gut Microbiota in Patients with Post-Stroke Comorbid Cognitive Impairment and Depression and Its Correlation with Clinical Features	32
In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer’s Brain Tissue	32
Potential Involvement of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1	32
Soluble Amyloid-β Consumption in Alzheimer’s Disease	32
Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer’s Disease: A Blinded Validation Study	32
Copper Imbalance in Alzheimer’s Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology	31
Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study	31
Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials	31
Proteomic Profiling of Plasma and Brain Tissue from Alzheimer’s Disease Patients Reveals Candidate Network of Plasma Biomarkers	31
Predicting Cognitive Impairment and Dementia: A Machine Learning Approach	31
The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up	30
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Doub	30
Classification of Alzheimer’s Disease with Respect to Physiological Aging with Innovative EEG Biomarkers in a Machine Learning Implementation	30
Burnout of Healthcare Workers in Acute Care Geriatric Facilities During the COVID-19 Crisis: An Online-Based Study	30
Role of Executive Functions in the Conversion from Mild Cognitive Impairment to Dementia	30
Drug Repositioning for Alzheimer’s Disease: Finding Hidden Clues in Old Drugs	30
Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review	30
Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice	30
Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer’s Disease and Frontotemporal Dementia	29
Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study	29
lncRNA SNHG1 Knockdown Alleviates Amyloid-β-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer’s Disease	29
Selective Secretase Targeting for Alzheimer’s Disease Therapy	29
Dementia Care in the Time of COVID-19 Pandemic	29
From Polygenic Scores to Precision Medicine in Alzheimer’s Disease: A Systematic Review	29
MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults	29
A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer’s Disease	29
The Role of D-Amino Acids in Alzheimer’s Disease	29
RETRACTED: The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy1	29
Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer’s Disease Continuum Identified by Arterial Spin Labeling MRI	28
Effect of a Multimodal Lifestyle Intervention on Sleep and Cognitive Function in Older Adults with Probable Mild Cognitive Impairment and Poor Sleep: A Randomized Clinical Trial	28
Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model	28
Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer’s Disease Spectrum	28
Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer’s Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers	28
Link Between Dietary Sodium Intake, Cognitive Function, and Dementia Risk in Middle-Aged and Older Adults: A Systematic Review	28
Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer’s Disease	28
Vitamin B12, B6, or Folate and Cognitive Function in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis	28
Alpha Power and Functional Connectivity in Cognitive Decline: A Systematic Review and Meta-Analysis	28
Mind Diet Adherence and Cognitive Performance in the Framingham Heart Study	28
Dendrobium nobile Lindl. Alkaloids Ameliorate Cognitive Dysfunction in Senescence Accelerated SAMP8 Mice by Decreasing Amyloid-β Aggregation and Enhancing Autophagy Activity	28
Social Stigma of People with Dementia	28
Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer’s Disease from Controls and Predict Progression from Mild Cognitive Impairment	28
Quantitative Assessment of Resting-State for Mild Cognitive Impairment Detection: A Functional Near-Infrared Spectroscopy and Deep Learning Approach	27
Air Pollution Neurotoxicity in the Adult Brain: Emerging Concepts from Experimental Findings	27
Social Robot Interventions for People with Dementia: A Systematic Review on Effects and Quality of Reporting	27
Low Doses of Ionizing Radiation as a Treatment for Alzheimer’s Disease: A Pilot Study	27
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease	27
Inflammation: A Major Target for Compounds to Control Alzheimer’s Disease	27
Low Dose Brain Irradiation Reduces Amyloid-β and Tau in 3xTg-AD Mice	27
Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study	27
Effects of Chronic Masitinib Treatment in APPswe/PSEN1dE9 Transgenic Mice Modeling Alzheimer’s Disease	27
Effects of Palmitoylethanolamide Combined with Luteoline on Frontal Lobe Functions, High Frequency Oscillations, and GABAergic Transmission in Patients with Frontotemporal Dementia	27
Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer’s Disease Research	27
Severe Obstructive Sleep Apnea Is Associated with Higher Brain Amyloid Burden: A Preliminary PET Imaging Study	26
Association Between Inflammatory Bowel Disease and Dementia: A Retrospective Cohort Study	26
Photobiomodulation Enhances Memory Processing in Older Adults with Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy Study	26
Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer’s Disease	26
Design and Rationale of the PACt-MD Randomized Clinical Trial: Prevention of Alzheimer’s dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment a	26
Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer’s Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study	26
Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies	26
Towards a Redefinition of Cognitive Frailty	26
Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer’s Disease	26
The Effects of Propofol and Sevoflurane on Postoperative Delirium in Older Patients: A Randomized Clinical Trial Study	26
Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer’s Disease	26
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease	26
Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer’s Disease	26
Mesenchymal Stem Cell-Conditioned Medium Improves Mitochondrial Dysfunction and Suppresses Apoptosis in Okadaic Acid-Treated SH-SY5Y Cells by Extracellular Vesicle Mitochondrial Transfer	26
Protective Role of Cerebrospinal Fluid Inflammatory Cytokines in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer’s Disease Carrying Apolipoprotein E4 Genotype	26
Diabetes Mellitus Increases Risk of Incident Dementia in APOE ɛ4 Carriers: A Meta-Analysis	25
Photobiomodulation Therapy for Dementia: A Systematic Review of Pre-Clinical and Clinical Studies	25

Recursive Support Vector Machine Biomarker Selection for Alzheimer’s Disease	25
Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer’s	25
Blood-Based ATN Biomarkers of Alzheimer’s Disease: A Meta-Analysis	25
Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals	25
Sleep Quality, Depression, and Cognitive Function in Non-Demented Older Adults	25
Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic	25
Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review	25
Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer’s Disease	25
Functional Connectivity Alterations of the Temporal Lobe and Hippocampus in Semantic Dementia and Alzheimer’s Disease	25
Common Bacterial Infections and Risk of Dementia or Cognitive Decline: A Systematic Review	25
A Narrative Review of Alzheimer’s Disease Stigma	25
Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer’s Disease	25
Classifying Non-Dementia and Alzheimer’s Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test	24
Traffic-Related Air Pollution and Incident Dementia: Direct and Indirect Pathways Through Metabolic Dysfunction	24
Probiotic Bifidobacterium breve Prevents Memory Impairment Through the Reduction of Both Amyloid-β Production and Microglia Activation in APP Knock-In Mouse1	24
Ethnic Differences in Dementia Risk: A Systematic Review and Meta-Analysis	24
Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer’s and Parkinson’s Diseases in Young Urbanites Exposed to Air Pollution	24
Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project	24
Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer’s Disease	23
Alzheimer’s Disease, Neural Plasticity, and Functional Recovery	23
Pharmaceutical Treatment for Alzheimer’s Disease and Related Dementias: Utilization and Disparities	23
Improving Choroid Plexus Segmentation in the Healthy and Diseased Brain: Relevance for Tau-PET Imaging in Dementia	23
Design Considerations for Mobile Health Applications Targeting Older Adults	23
In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer’s Disease	23
Phenylalanine Metabolism Is Dysregulated in Human Hippocampus with Alzheimer’s Disease Related Pathological Changes	23
Long-Term Blood Pressure Variability Across the Clinical and Biomarker Spectrum of Alzheimer’s Disease	23
Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer’s Disease	23
Loneliness, Not Social Support, Is Associated with Cognitive Decline and Dementia Across Two Longitudinal Population-Based Cohorts	23
Key Intervention Categories to Provide Person-Centered Dementia Care: A Systematic Review of Person-Centered Interventions	22
Neuromodulation for Apathy in Alzheimer’s Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study	22
Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation	22
Cardiac Surgery is Associated with Biomarker Evidence of Neuronal Damage	22
Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer’s Disease: A Case Series1	22
Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer’s Disease	22
A Comparison of Traditional and Serious Game-Based Digital Markers of Cognition in Older Adults with Mild Cognitive Impairment and Healthy Controls	22
Model-Based Projection of Dementia Prevalence in China and Worldwide: 2020–2050	22
Low Liver Enzymes and Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study	22
Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer’s Disease	22
Ethical Issues Raised by the Introduction of Artificial Companions to Older Adults with Cognitive Impairment: A Call for Interdisciplinary Collaborations	22
Associations of Infectious Agents with Alzheimer’s Disease: A Systematic Review and Meta-Analysis	22
Association of Cerebral Microbleeds with Cognitive Decline: A Longitudinal Study	22
Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer’s Disease and Incident Mild Cognitive Impairment: Implications for Defining	22
RETRACTED: Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-β-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind,	22
Neurodegeneration of Trigeminal Mesencephalic Neurons by the Tooth Loss Triggers the Progression of Alzheimer’s Disease in 3×Tg-AD Model Mice	22
Can Social Cognition Measurements Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer’s Disease Regardless of Apathy?	22
COVID-19 Crisis Effects on Caregiver Distress in Neurocognitive Disorder	22
A Systematic Review of the Association Between Psychological Stress and Dementia Risk in Humans	21
Role of Hypoxia Inducible Factor-1α in Alzheimer’s Disease	21
Association of Glaucoma and Cataract with Incident Dementia: A 5-Year Follow-Up in the Shanghai Aging Study	21
The Potential Contribution of Chronic Pain and Common Chronic Pain Conditions to Subsequent Cognitive Decline, New Onset Cognitive Impairment, and Incident Dementia: A Systematic Review and Conceptual	21
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study	21
Multidomain Intervention for Reversal of Cognitive Frailty, Towards a Personalized Approach (AGELESS Trial): Study Design	21
Mortality in Dementia from 1996 to 2015: A National Registry-Based Cohort Study	21
Non-Coding RNAs Based Molecular Links in Type 2 Diabetes, Ischemic Stroke, and Vascular Dementia	21
Electroacupuncture Enhances Cognition by Promoting Brain Glucose Metabolism and Inhibiting Inflammation in the APP/PS1 Mouse Model of Alzheimer’s Disease: A Pilot Study	21
Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses	21
Spatial Pattern Separation in Early Alzheimer’s Disease	21
Screening for Early-Stage Alzheimer’s Disease Using Optimized Feature Sets and Machine Learning	21
Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer’s Disease	21
Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer’s Disease and Mild Cognitive Impairment	21
High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer’s Disease-Causing Mutations	21
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer’s Disease Reveals Sex Differences	20
Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice	20
Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer’s Disease Using Change-Point Analysis	20
Fiat Lux: The Light Became Therapy. An Overview on the Bright Light Therapy in Alzheimer’s Disease Sleep Disorders	20
Age of Migration and Cognitive Function Among Older Latinos in the United States	20
Education as Proxy for Cognitive Reserve in a Large Elderly Memory Clinic: ‘Window of Benefit’	20
Aggregates of RNA Binding Proteins and ER Chaperones Linked to Exosomes in Granulovacuolar Degeneration of the Alzheimer’s Disease Brain	20
A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer’s Disease	20
Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment	20
Tenuifolin Attenuates Amyloid-β42-Induced Neuroinflammation in Microglia Through the NF-κB Signaling Pathway	20
Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus	20
Age Moderates Associations of Hypertension, White Matter Hyperintensities, and Cognition	20
Metabotropic Glutamate Receptors in Alzheimer’s Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future	20
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome	20
Impact of Serum Calcium Levels on Alzheimer’s Disease: A Mendelian Randomization Study	20
Reliability of Telephone and Videoconference Methods of Cognitive Assessment in Older Adults with and without Dementia	20
Quantifying and Describing the Natural History and Costs of Alzheimer’s Disease and Effects of Hypothetical Interventions	20
Does Mild Traumatic Brain Injury Increase the Risk for Dementia? A Systematic Review and Meta-Analysis	20
Obesity Measures in Relation to Cognition in the Northern Manhattan Study	20
Patterns of Regional Cerebral Blood Flow as a Function of Obesity in Adults	20
A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer’s Disease1	20
Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer’s Disease Pathology1	20
A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer’s Disease	20
Cognitive Impairment and Associated Factors in Rural Elderly in North China	20
Corneal Nerve and Brain Imaging in Mild Cognitive Impairment and Dementia	20
Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells	20
The Neuroprotective and Neurodegeneration Effects of Heme Oxygenase-1 in Alzheimer’s Disease	19
Potential Novel Genes for Late-Onset Alzheimer’s Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study	19
Impact of 3-Day Combined Anodal Transcranial Direct Current Stimulation-Visuospatial Training on Object-Location Memory in Healthy Older Adults and Patients with Mild Cognitive Impairment	19
Acceptance and Usability of Immersive Virtual Reality in Older Adults with Objective and Subjective Cognitive Decline	19
M2-Like Microglia Polarization Attenuates Neuropathic Pain Associated with Alzheimer’s Disease	19
Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy?	19
Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer’s Disease and Inflammation at the Pre- and Early Stages of Dementia	19
Retinal Amyloid Imaging for Screening Alzheimer’s Disease	19